101 related articles for article (PubMed ID: 2823826)
1. L-652,343, a novel dual cyclo/lipoxygenase inhibitor, inhibits LTB4-production by stimulated human polymorphonuclear cells but not by stimulated human whole blood.
Gresele P; Arnout J; Deckmyn H; Vermylen J
Biochem Pharmacol; 1987 Oct; 36(20):3529-31. PubMed ID: 2823826
[No Abstract] [Full Text] [Related]
2. CP-66,248, a new anti-inflammatory agent, is a potent inhibitor of leukotriene B4 and prostanoid synthesis in human polymorphonuclear leucocytes in vitro.
Moilanen E; Alanko J; Asmawi MZ; Vapaatalo H
Eicosanoids; 1988; 1(1):35-9. PubMed ID: 2856170
[TBL] [Abstract][Full Text] [Related]
3. Effects of antirheumatic drugs on leukotriene B4 and prostanoid synthesis in human polymorphonuclear leukocytes in vitro.
Moilanen E; Alanko J; Seppälä E; Vapaatalo H
Agents Actions; 1988 Jul; 24(3-4):387-94. PubMed ID: 2845746
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of the butanamide derivative S 19812, a new dual inhibitor of cyclooxygenase and lipoxygenase pathways.
Tordjman C; Sauveur F; Droual M; Briss S; Andre N; Bellot I; Deschamps C; Wierzbicki M
Arzneimittelforschung; 2003; 53(11):774-9. PubMed ID: 14677373
[TBL] [Abstract][Full Text] [Related]
5. Orally administered tolfenamic acid inhibits leukotriene synthesis in isolated human peripheral polymorphonuclear leukocytes.
Moilanen E; Alanko J; Juhakoski A; Vapaatalo H
Agents Actions; 1989 Aug; 28(1-2):83-8. PubMed ID: 2551152
[TBL] [Abstract][Full Text] [Related]
6. Effect of manoalide on human 5-lipoxygenase activity.
Cabré F; Carabaza A; Suesa N; García AM; Rotllan E; Gómez M; Tost D; Mauleón D; Carganico G
Inflamm Res; 1996 May; 45(5):218-23. PubMed ID: 8737743
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of inhibitors of eicosanoid synthesis in leukocytes: possible pitfall of using the calcium ionophore A23187 to stimulate 5' lipoxygenase.
Salmon JA; Tilling LC; Moncada S
Prostaglandins; 1985 Mar; 29(3):377-85. PubMed ID: 2988019
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory activity of a series of coumarins on leukocyte eicosanoid generation.
Hoult JR; Forder RA; de las Heras B; Lobo IB; Payá M
Agents Actions; 1994 Aug; 42(1-2):44-9. PubMed ID: 7847183
[TBL] [Abstract][Full Text] [Related]
9. Leukotriene B4 production by stimulated whole blood: comparative studies with isolated polymorphonuclear cells.
Gresele P; Arnout J; Coene MC; Deckmyn H; Vermylen J
Biochem Biophys Res Commun; 1986 May; 137(1):334-42. PubMed ID: 3013186
[TBL] [Abstract][Full Text] [Related]
10. Ca2+ ionophore A23187-stimulated secretion of azurophil granules in human polymorphonuclear leukocytes is largely mediated by endogenously formed leukotriene B4.
Hatzelmann A; Fruchtmann R; Mohrs KH; Raddatz S; Müller-Peddinghaus R
Biochem Pharmacol; 1994 Jul; 48(1):31-9. PubMed ID: 8043028
[TBL] [Abstract][Full Text] [Related]
11. Tenidap inhibits 5-lipoxygenase product formation in vitro, but this activity is not observed in three animal models.
Carty TJ; Sweeney FJ; Griffiths RJ; Eskra JD; Ernest MJ; Pillar JS; Cheng JD; Loose LD; Joseph PA; Pazoles PP; Moore PF; Nagahisa A; Murase S; Kadin SB
Inflamm Res; 1997 May; 46(5):168-79. PubMed ID: 9197987
[TBL] [Abstract][Full Text] [Related]
12. Nicotine and cotinine modulate eicosanoid production in human leukocytes and platelet rich plasma.
Saareks V; Riutta A; Mucha I; Alanko J; Vapaatalo H
Eur J Pharmacol; 1993 Dec; 248(4):345-9. PubMed ID: 8181543
[TBL] [Abstract][Full Text] [Related]
13. A prodrug of a 2,6-disubstituted 4-(2-arylethenyl)phenol is a selective and orally active 5-lipoxygenase inhibitor.
Farina PR; Graham AG; Homon CA; Lazer ES; Hattox SE; Riska PS; Gundel RH; Wegner CD
J Pharmacol Exp Ther; 1993 May; 265(2):483-9. PubMed ID: 8388452
[TBL] [Abstract][Full Text] [Related]
14. Differential inhibition of thromboxane B2 and leukotriene B4 biosynthesis by two naturally occurring acetylenic fatty acids.
Croft KD; Beilin LJ; Ford GL
Biochim Biophys Acta; 1987 Oct; 921(3):621-4. PubMed ID: 2822134
[TBL] [Abstract][Full Text] [Related]
15. Lung cancer cell lines inhibit leukotriene B4 production by human polymorphonuclear leukocytes at the level of phospholipase A2.
Abe M; Matsuki H; Domae M; Kuwata H; Kudo I; Nakanishi Y; Hara N; Mitsuyama T; Furukawa T
Am J Respir Cell Mol Biol; 1996 Nov; 15(5):565-73. PubMed ID: 8918363
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the effects of some compounds on human neutrophil degranulation and leukotriene B4 and thromboxane B2 synthesis.
Palmer RM; Salmon JA
Biochem Pharmacol; 1985 May; 34(9):1485-90. PubMed ID: 2986647
[TBL] [Abstract][Full Text] [Related]
17. Effects of tetrandrine on production of leukotriene B4 and thromboxane B2 in rabbit blood.
Du ZY; Huang YH
Zhongguo Yao Li Xue Bao; 1993 Jul; 14(4):325-8. PubMed ID: 8249626
[TBL] [Abstract][Full Text] [Related]
18. In vitro pharmacology of BAY X1005, a new inhibitor of leukotriene synthesis.
Fruchtmann R; Mohrs KH; Hatzelmann A; Raddatz S; Fugmann B; Junge B; Horstmann H; Müller-Peddinghaus R
Agents Actions; 1993 Mar; 38(3-4):188-95. PubMed ID: 8213345
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the antiinflammatory activity of a dual cyclooxygenase-2 selective/5-lipoxygenase inhibitor, RWJ 63556, in a canine model of inflammation.
Kirchner T; Argentieri DC; Barbone AG; Singer M; Steber M; Ansell J; Beers SA; Wachter MP; Wu W; Malloy E; Stewart A; Ritchie DM
J Pharmacol Exp Ther; 1997 Aug; 282(2):1094-101. PubMed ID: 9262379
[TBL] [Abstract][Full Text] [Related]
20. Release of leukotriene B4 from human neutrophils and its relationship to degranulation induced by N-formyl-methionyl-leucyl-phenylalanine, serum-treated zymosan and the ionophore A23187.
Palmer RM; Salmon JA
Immunology; 1983 Sep; 50(1):65-73. PubMed ID: 6309653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
